08 Apr 2021 Oxurion NV – Publication in Progress in Retinal Eye Research highlights the potential of pan-RGD integrin antagonists to improve the treatment of diabetic retinopathy and wet AMD Member news
31 Mar 2021 Complix and VIB publish pioneering study on Cell-Penetrating Alphabodies in Science Advances Member news
23 Mar 2021 Augustine Therapeutics awarded EUR 1.2 million VLAIO research grant to develop new medicines for neuromuscular diseases Member news
22 Mar 2021 Biocartis launches Idylla™ GeneFusion Assay as rapid lab workflow solution for gene fusion testing Member news
22 Mar 2021 ViroVet successful with second vaccine based on new vaccine technology, Rega Institute assesses development of human version Member news
22 Mar 2021 Consortium led by eTheRNA immunotherapies awarded EU Commission TIGER Grant of EUR 6.9 million Member news
19 Mar 2021 Augustine Therapeutics strengthens Board of Directors and sets up Scientific Advisory Board Member news
18 Mar 2021 FOx BIOSYSTEMS launches the White FOx, its new generation biosensor with fiber-optic surface plasmon resonance Member news
11 Mar 2021 Complix signs global drug discovery and development agreement with I-Mab to develop cell penetrating alphabodies against two intracellular immuno-oncology targets Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
